查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386216

卵巢癌诊断市场报告：2030 年趋势、预测与竞争分析

Ovarian Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

卵巢癌诊断的趋势和预测

预计到 2030 年，全球卵巢诊断市场将达到 22.7 亿美元，2024 年至 2030 年年复合成长率为 6.9%。该市场的主要驱动因素是卵巢癌盛行率的增加、癌症意识的提高以及对改进和增强诊断过程和技术的需求不断增加。由于癌症诊断中心、医院实验室和研究机构市场的商机，全球卵巢癌诊断市场前景看好。

卵巢癌诊断市场洞察

Lucintel 预测诊断影像将在预测期内实现最高成长，并且更加重视癌症的早期检测和分期。

在这个市场中，由于越来越多的患者涌入医院进行癌症诊断、消费者意识的提高以及医疗基础设施投资的增加，医院实验室将继续成为最大的细分市场。

由于卵巢癌发病率不断上升、老年人口迅速增长以及该地区主要市场参与企业的存在，预计北美在预测期内仍将是最大的地区。

市场规模/估计：以金额的卵巢癌诊断市场规模估计（10 亿美元）。

趋势和预测分析：各个细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）。

細項分析：按产品类型、诊断类型、癌症类型和金额地区（十亿美元）估计卵巢癌诊断市场规模。

区域分析：北美、欧洲、亚太地区以及世界其他地区、中东和非洲的卵巢癌诊断市场细分。

成长机会：依产品类型、诊断类型、癌症类型和卵巢癌诊断市场区域进行成长机会分析。

策略分析：卵巢癌诊断市场的併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球卵巢癌诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球卵巢癌诊断市场趋势（2018-2023）与预测（2024-2030）
  • 全球卵巢癌诊断市场（按产品）
    • 装置
    • 试剂盒和试剂
  • 按诊断类型分類的全球卵巢癌诊断市场
    • 影像
    • 验血
    • 切片检查
    • 其他的
  • 按癌症类型分類的全球卵巢诊断市场
    • 上皮性肿瘤
    • 生殖细胞
    • 间质细胞瘤
  • 全球卵巢癌诊断市场（依最终用途）
    • 癌症诊断中心
    • 医院实验室
    • 研究机构
    • 其他的

第4章2018-2030年分地区市场趋势及预测分析

  • 全球卵巢诊断市场（按地区）
  • 北美卵巢癌诊断市场
  • 欧洲卵巢癌诊断市场
  • 亚太地区卵巢癌诊断市场
  • 其他地区卵巢癌诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球卵巢癌诊断市场成长机会（按产品）
    • 按诊断类型分類的全球卵巢癌诊断市场成长机会
    • 按癌症类型分類的全球卵巢诊断市场成长机会
    • 全球卵巢癌诊断市场成长机会（依最终用途）
    • 全球卵巢癌诊断市场按地区成长机会
  • 全球卵巢癌诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 全球卵巢诊断市场的产能扩张
    • 全球卵巢癌诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • F. Hoffmann-La Roche
  • Tosoh
  • Luminex Corporation
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific
  • Ngenebio
  • Abbott
  • Siemens healthcare
  • Myriad genetics
  • Bio-rad laboratories
简介目录

Ovarian Cancer Diagnostics Trends and Forecast

The future of the global ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets. The global ovarian cancer diagnostics market is expected to reach an estimated $2.27 billion by 2030 with a CAGR of 6.9% from 2024 to 2030. The major drivers for this market are growing prevalence of ovarian cancer, increasing awareness towards cancer, and rising demand for improved and enhanced diagnostic processess and techniques.

A more than 150-page report is developed to help in your business decisions.

Ovarian Cancer Diagnostics by Segment

The study includes a forecast for the global ovarian cancer diagnostics by product, diagnosis type, cancer type, end use, and region.

Ovarian Cancer Diagnostics Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Kits and Reagents

Ovarian Cancer Diagnostics Market by Diagnosis Type [Shipment Analysis by Value from 2018 to 2030]:

  • Imaging
  • Blood Test
  • Biopsy
  • Others

Ovarian Cancer Diagnostics Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:

  • Epithelial Tumor
  • Germ Cell
  • Stromal Cell Tumor

Ovarian Cancer Diagnostics Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Cancer Diagnostic Centers
  • Hospital Laboratories
  • Research Institutes
  • Others

Ovarian Cancer Diagnostics Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ovarian Cancer Diagnostics Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ovarian cancer diagnostics companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ovarian cancer diagnostics companies profiled in this report include-

  • F. Hoffmann-La Roche
  • Tosoh
  • Luminex Corporation
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific
  • Ngenebio
  • Abbott
  • Siemens Healthcare
  • Myriad Genetics
  • Bio-Rad Laboratories

Ovarian Cancer Diagnostics Market Insights

Lucintel forecasts that imaging is expected to witness highest growth over the forecast period due to the growing emphasis on early cancer detection and staging.

Within this market, hospital laboratories will remain the largest segment due to growing inflow of patient for cancer diagnosis in hospitals, rising consumer awareness, and increasing investments in healthcare infrastructures.

North America will remain the largest region over the forecast period due to increasing icidence of ovarian cancer, surge in elderly population, and presence of leading market players in the region.

Features of the Global Ovarian Cancer Diagnostics Market

Market Size Estimates: Ovarian cancer diagnostics market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ovarian cancer diagnostics market size by product, diagnosis type, cancer type, and region in terms of value ($B).

Regional Analysis: Ovarian cancer diagnostics market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, diagnosis types, cancer types, and regions for the ovarian cancer diagnostics market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ovarian cancer diagnostics market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the ovarian cancer diagnostics market size?

Answer: The global ovarian cancer diagnostics market is expected to reach an estimated $2.27 billion by 2030.

Q.2 What is the growth forecast for ovarian cancer diagnostics market?

Answer: The global ovarian cancer diagnostics market is expected to grow with a CAGR of 6.9% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the ovarian cancer diagnostics market?

Answer: The major drivers for this market are growing prevalence of ovarian cancer, increasing awareness towards cancer, and rising demand for improved and enhanced diagnostic processess and techniques.

Q4. What are the major segments for ovarian cancer diagnostics market?

Answer: The future of the ovarian cancer diagnostics market looks promising with opportunities in the cancer diagnostic center, hospital laboratory, and research institute markets.

Q5. Who are the key ovarian cancer diagnostics market companies?

Answer: Some of the key ovarian cancer diagnostics companies are as follows:

  • F. Hoffmann-La Roche
  • Tosoh
  • Luminex Corporation
  • Quest Diagnostics Incorporated
  • Thermo Fisher Scientific
  • Ngenebio
  • Abbott
  • Siemens healthcare
  • Myriad genetics
  • Bio-rad laboratories

Q6. Which ovarian cancer diagnostics market segment will be the largest in future?

Answer: Lucintel forecasts that imaging is expected to witness highest growth over the forecast period due to the growing emphasis on early cancer detection and staging.

Q7. In ovarian cancer diagnostics market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to increasing icidence of ovarian cancer, surge in elderly population, and presence of leading market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ovarian cancer diagnostics market by product (instruments and kits & reagents), diagnosis type (imaging, blood test, biopsy, and others), cancer type (epithelial tumor, germ cell, and stromal cell tumor), end use (cancer diagnostic centers, hospital laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ovarian Cancer Diagnostics Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ovarian Cancer Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ovarian Cancer Diagnostics Market by Product
    • 3.3.1: Instruments
    • 3.3.2: Kits and Reagents
  • 3.4: Global Ovarian Cancer Diagnostics Market by Diagnosis Type
    • 3.4.1: Imaging
    • 3.4.2: Blood Test
    • 3.4.3: Biopsy
    • 3.4.4: Others
  • 3.5: Global Ovarian Cancer Diagnostics Market by Cancer Type
    • 3.5.1: Epithelial Tumor
    • 3.5.2: Germ Cell
    • 3.5.3: Stromal Cell Tumor
  • 3.6: Global Ovarian Cancer Diagnostics Market by End Use
    • 3.6.1: Cancer Diagnostic Centers
    • 3.6.2: Hospital Laboratories
    • 3.6.3: Research Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ovarian Cancer Diagnostics Market by Region
  • 4.2: North American Ovarian Cancer Diagnostics Market
    • 4.2.2: North American Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
  • 4.3: European Ovarian Cancer Diagnostics Market
    • 4.3.1: European Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
    • 4.3.2: European Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
  • 4.4: APAC Ovarian Cancer Diagnostics Market
    • 4.4.1: APAC Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
    • 4.4.2: APAC Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
  • 4.5: ROW Ovarian Cancer Diagnostics Market
    • 4.5.1: ROW Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
    • 4.5.2: ROW Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Product
    • 6.1.2: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Diagnosis Type
    • 6.1.3: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Cancer Type
    • 6.1.4: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by End Use
    • 6.1.5: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Region
  • 6.2: Emerging Trends in the Global Ovarian Cancer Diagnostics Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ovarian Cancer Diagnostics Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovarian Cancer Diagnostics Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: F. Hoffmann-La Roche
  • 7.2: Tosoh
  • 7.3: Luminex Corporation
  • 7.4: Quest Diagnostics Incorporated
  • 7.5: Thermo Fisher Scientific
  • 7.6: Ngenebio
  • 7.7: Abbott
  • 7.8: Siemens healthcare
  • 7.9: Myriad genetics
  • 7.10: Bio-rad laboratories